129 related articles for article (PubMed ID: 29110291)
1. Non-ionic Surfactant Based In Situ Forming Vesicles as Controlled Parenteral Delivery Systems.
Ammar HO; Ibrahim M; Mahmoud AA; Shamma RN; El Hoffy NM
AAPS PharmSciTech; 2018 Apr; 19(3):1001-1010. PubMed ID: 29110291
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of injectable in situ forming microparticles for sustained delivery of lornoxicam.
Yehia SA; Abdel-Halim SA; Aziz MY
Drug Dev Ind Pharm; 2017 Feb; 43(2):319-328. PubMed ID: 27671477
[TBL] [Abstract][Full Text] [Related]
3. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
[TBL] [Abstract][Full Text] [Related]
4. Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole.
Basha M; Abd El-Alim SH; Shamma RN; Awad GE
J Liposome Res; 2013 Sep; 23(3):203-10. PubMed ID: 23607316
[TBL] [Abstract][Full Text] [Related]
5. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S
Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633
[TBL] [Abstract][Full Text] [Related]
6. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.
Marianecci C; Paolino D; Celia C; Fresta M; Carafa M; Alhaique F
J Control Release; 2010 Oct; 147(1):127-35. PubMed ID: 20603167
[TBL] [Abstract][Full Text] [Related]
7. Nonionic surfactant structure on the drug release, formulation and physical properties of ethylcellulose microspheres.
Thakare M; Israel B; Garner S; Ahmed H; Elder D; Capomacchia A
Pharm Dev Technol; 2017 May; 22(3):418-425. PubMed ID: 27499352
[TBL] [Abstract][Full Text] [Related]
8. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
Al-Mahallawi AM; Abdelbary AA; Aburahma MH
Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
[TBL] [Abstract][Full Text] [Related]
9. Nanoemulsifying drug delivery system to improve the bioavailability of piroxicam.
Motawea A; Borg T; Tarshoby M; Abd El-Gawad AE
Pharm Dev Technol; 2017 May; 22(3):445-456. PubMed ID: 27583581
[TBL] [Abstract][Full Text] [Related]
10. Effect of different polysorbates on development of self-microemulsifying drug delivery systems using medium chain lipids.
Shah A; Thool P; Sorathiya K; Prajapati H; Dalrymple D; Serajuddin ATM
Drug Dev Ind Pharm; 2018 Feb; 44(2):215-223. PubMed ID: 29057677
[TBL] [Abstract][Full Text] [Related]
11. Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation.
Jangdey MS; Gupta A; Saraf S; Saraf S
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1452-1462. PubMed ID: 28050929
[TBL] [Abstract][Full Text] [Related]
12. Formulation and physiochemical study of α-tocopherol based oil in water nanoemulsion stabilized with non toxic, biodegradable surfactant: Sodium stearoyl lactate.
Kaur K; Kaur J; Kumar R; Mehta SK
Ultrason Sonochem; 2017 Sep; 38():570-578. PubMed ID: 27566966
[TBL] [Abstract][Full Text] [Related]
13. Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20.
Di Marzio L; Marianecci C; Petrone M; Rinaldi F; Carafa M
Colloids Surf B Biointerfaces; 2011 Jan; 82(1):18-24. PubMed ID: 20832262
[TBL] [Abstract][Full Text] [Related]
14. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
Patel N; Nakrani H; Raval M; Sheth N
Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
[TBL] [Abstract][Full Text] [Related]
15. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
[TBL] [Abstract][Full Text] [Related]
16. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
[TBL] [Abstract][Full Text] [Related]
17. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA
Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516
[TBL] [Abstract][Full Text] [Related]
18. Impact of various solid carriers and spray drying on pre/post compression properties of solid SNEDDS loaded with glimepiride: in vitro-ex vivo evaluation and cytotoxicity assessment.
Rajesh SY; Singh SK; Pandey NK; Sharma P; Bawa P; Kumar B; Gulati M; Jain SK; Gowthamarajan K; Singh S
Drug Dev Ind Pharm; 2018 Jul; 44(7):1056-1069. PubMed ID: 29360412
[TBL] [Abstract][Full Text] [Related]
19. Development of microemulsions of suitable viscosity for cyclosporine skin delivery.
Benigni M; Pescina S; Grimaudo MA; Padula C; Santi P; Nicoli S
Int J Pharm; 2018 Jul; 545(1-2):197-205. PubMed ID: 29698819
[TBL] [Abstract][Full Text] [Related]
20. Efavirenz Self-Nano-Emulsifying Drug Delivery System: In Vitro and In Vivo Evaluation.
Kamble RN; Mehta PP; Kumar A
AAPS PharmSciTech; 2016 Oct; 17(5):1240-7. PubMed ID: 26573159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
